Personal information

Netherlands

Activities

Employment (4)

Amsterdam UMC: Amsterdam, Noord-Holland, NL

2013-06-01 to present | Staff member/ medical specialist (Radiology and Nuclear medicine)
Employment
Source: Self-asserted source
Daniela-Elena Oprea-Lager

VU Amsterdam: Amsterdam, Noord-Holland, NL

2009-06-01 to 2013-05-31 | fellow/ Nuclear medicine physician (Nuclear Medicine and PET Research)
Employment
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Leiden University Medical Center: Leiden, Zuid-Holland, NL

2006-05-01 to 2009-04-30 | Nuclear medicine resident (Radiology and Nuclear Medicine)
Employment
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Twee Steden ziekenhuis: Tilburg, Brabant, NL

2005-05-01 to 2006-04-30 | Internal Medicine resident (Internal Medicine)
Employment
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Education and qualifications (7)

VU Amsterdam: Amsterdam, Noord-Holland, NL

2011-01-02 to 2016-02-16 | PhD
Qualification
Source: Self-asserted source
Daniela-Elena Oprea-Lager

PhD Project (Research: 1 day/ week): Amsterdam, Noord-Holland, NL

2011-01-02 to 2016-02-16 | PhD (Radiology and Nuclear Medicine)
Education
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Leiden University: Leiden, NL

2002-09-01 to 2014-12-17 | MD
Qualification
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Leiden University Medical Center: Leiden, NL

2005-05-01 to 2009-04-30 | Nuclear Medicine Specialist (Radiology and nuclear Medicine)
Education
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Technische Universiteit Delft Reactor Instituut Delft: Delft, Zuid-Holland, NL

2007-09-01 to 2007-12-10 | Radiation Hygiene Diploma, Expertise level 3
Qualification
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Leiden University: Leiden, NL

2002-09-01 to 2004-12-17 | Medical Doctor, MD
Education
Source: Self-asserted source
Daniela-Elena Oprea-Lager

University of Medicine and Pharmacy of Târgu Mureş: Târgu Mureş, RO

1994-10-01 to 2000-09-15 | MD
Education
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Professional activities (12)

European Association of Nuclear Medicine: Wien, AT

Associate panel member Imaging
Invited position
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Organisation for Research and Treatment of Cancer: Brussels, BE

2020-01-02 to present | Chair Imaging/ Subcommitte Oligometastases
Invited position
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Association of Urology: Arnhem, NL

2020-01-02 to present | Associate panel member
Invited position
Source: Self-asserted source
Daniela-Elena Oprea-Lager

PSMA Forum Netherlands: Amsterdam, NL

2019-03-01 to present | Chair
Invited position
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Society of Urology: Vienna, AT

2018-01-01 to present | Member
Membership
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Nederlandse Vereniging voor Radiologie: Vught, NL

2017-01-01 to present | Member
Service
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Society of Radiology: Vienna, AT

2017-01-01 to present | Member
Membership
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Society of Oncological Imaging: Amsterdam, NL

2017-01-01 to present | Member
Membership
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Society for Radiotherapy and Oncology: Brussels, BE

2017-01-01 to present | Member
Membership
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Society for Medical Oncology: Viganello, TI, CH

2017-01-01 to present | Member
Service
Source: Self-asserted source
Daniela-Elena Oprea-Lager

European Association of Nuclear Medicine: Wien, AT

2009-01-01 to present | Associate member Imaging
Membership
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Nederlandse Vereniging voor Nucleaire Geneeskunde: Utrecht, NL

2005-05-01 to present | Member
Membership
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Funding (6)

18F-Prostate Specific Membrane Antigen PET-CT as a potential novel imaging modality for

2020-02 to present | Grant
Cancer Center amsterdam (Amsterdam, NL)
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

2020-01 to present | Grant
IMI EU (Amsterdam, NL)
Source: Self-asserted source
Daniela-Elena Oprea-Lager

PSMA-PET/CT imaging in the EArly detection of Cancer of the Prostate with High Risk Features (PEACH trial, a pilot study)

2019-05 to present | Grant
Cancer Center Amsterdam (Amsterdam, NL)
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Assessing early treatment response to Radium-223-chloride and Rhenium-188-HEDP using 18F-Prostate Specific Membrane Antigen PET/CT imaging in patients with metastatic castration-resistant prostate cancer (RaRePET)

2018-12 to present | Grant
Cancer Center Amsterdam (Amsterdam, NL)
GRANT_NUMBER:

CCA2018-5-45

Source: Self-asserted source
Daniela-Elena Oprea-Lager

Characterising mechanisms of sensitivity and resistnace to ant-androgen theapy with whole-body molecular Imaging

2017-11 to present | Award
Movember Foundation (VIC, VIC, AU)
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Guiding personalized therapy of patients with metastatic prostate

2017-05 to 2019-10 | Grant
Cancer Center Amsterdam (Amsterdam, NL)
GRANT_NUMBER:

CCA2016-5-30

Source: Self-asserted source
Daniela-Elena Oprea-Lager

Works (50 of 57)

Items per page:
Page 1 of 2

[18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study

European Journal of Nuclear Medicine and Molecular Imaging
2023-09 | Journal article
Contributors: Daniela-Elena Oprea-Lager; Eric Gontier; Lina García-Cañamaque; Mathieu Gauthé; Pierre Olivier; Mercedes Mitjavila; Pilar Tamayo; Philippe Robin; Ana Maria García Vicente; Anne-Charlotte Bouyeure et al.
Source: check_circle
Crossref

[18F]FDG and [18F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

Clinical Cancer Research
2023-06-01 | Journal article
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Data from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Data from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S1 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S1 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S2 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S2 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S3 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S3 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S4 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Figure S4 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Methods S1 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Methods S1 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S1 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S1 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S2 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S2 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S3 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S3 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S4 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S4 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S5 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S5 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S6 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Supplementary Table S6 from [<sup>18</sup>F]FDG and [<sup>18</sup>F]FES PET/CT Imaging as a Biomarker for Therapy Effect in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant

2023-06-01 | Preprint
Contributors: Ramsha Iqbal; Maqsood Yaqub; Huseyyin O. Bektas; Daniela E. Oprea-Lager; Elisabeth G.E. de Vries; Andor W.J.M. Glaudemans; Philippe Aftimos; Géraldine Gebhart; Andrew P. Beelen; Robert C. Schuit et al.
Source: check_circle
Crossref

Lymph node classification in E‑PSMA reporting guidelines for PSMA‑PET

European Journal of Nuclear Medicine and Molecular Imaging
2022-12 | Journal article
Contributors: Daniela E. Oprea-Lager; Francesco Ceci; Matthias Eiber; Stefano Fanti; Ken Herrmann
Source: check_circle
Crossref

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography

BJU International
2022-12 | Journal article
Contributors: Hans Veerman; Maarten Donswijk; Elise Bekers; Yves J.L. Bodar; Dennie Meijer; R. Jeroen A. van Moorselaar; Daniela E. Oprea‐Lager; Vincent van der Noort; Pim J. van Leeuwen; André N. Vis et al.
Source: check_circle
Crossref

E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET

European Journal of Nuclear Medicine and Molecular Imaging
2021-05-19 | Journal article
Contributors: Francesco Ceci; Daniela E. Oprea-Lager; Louise Emmett; Judit A. Adam; Jamshed Bomanji; Johannes Czernin; Matthias Eiber; Uwe Haberkorn; Michael S. Hofman; Thomas A. Hope et al.
Source: check_circle
Crossref

Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers

Diagnostics
2021-01-13 | Journal article
Contributors: Wietske I. Luining; Dennie Meijer; Max R. Dahele; André N. Vis; Daniela E. Oprea-Lager
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

<sup>177</sup>Lutetium PSMA radioligand therapy in prostate cancer,<sup>177</sup>Lutetium PSMA-radioligandtherapie bij prostaatkanker

Tijdschrift voor Urologie
2020 | Journal article
EID:

2-s2.0-85078253771

Part of ISBN:

22114718 22113037

Contributors: Vis, A.N.; Jansen, B.H.E.; Bodar, Y.J.L.; Nieuwenhuijzen, J.A.; Hendrikse, H.N.; Oprea-Lager, D.E.
Source: Self-asserted source
Daniela-Elena Oprea-Lager via Scopus - Elsevier

Correction to: Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake (Molecular Imaging and Biology, (2020), 22, 1, (15-17), 10.1007/s11307-019-01438-y)

Molecular Imaging and Biology
2020 | Journal article
EID:

2-s2.0-85077526891

Part of ISBN:

18602002 15361632

Contributors: Cysouw, M.C.F.; Jansen, B.H.E.; Yaqub, M.; Voortman, J.; Vis, A.N.; van Moorselaar, R.J.A.; Hoekstra, O.S.; Boellaard, R.; Oprea-Lager, D.E.
Source: Self-asserted source
Daniela-Elena Oprea-Lager via Scopus - Elsevier

Impact of the COVID-19 crisis on imaging in oncological trials

European Journal of Nuclear Medicine and Molecular Imaging
2020 | Journal article
EID:

2-s2.0-85086463828

Part of ISBN:

16197089 16197070

Contributors: Deroose, C.M.; Lecouvet, F.E.; Collette, L.; Oprea-Lager, D.E.; Kunz, W.G.; Bidaut, L.; Verhoeff, J.J.C.; Caramella, C.; Lopci, E.; Tombal, B. et al.
Source: Self-asserted source
Daniela-Elena Oprea-Lager via Scopus - Elsevier

Detection of Recurrent Prostate Cancer Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients not Meeting the Phoenix Criteria for Biochemical Recurrence After Curative Radiotherapy

European Urology Oncology
2020-02 | Journal article
Part of ISSN: 2588-9311
Source: Self-asserted source
Daniela-Elena Oprea-Lager

Letter to the Editor re: Semiquantitative Parameters in PSMA-Targeted PET Imaging with [18F]DCFPyL: Impact of Tumor Burden on Normal Organ Uptake

Molecular Imaging and Biology
2020-02 | Journal article
Part of ISSN: 1536-1632
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 6)‎

Repeatability of Quantitative 18F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.

Journal of Nuclear Medicine
2020-01-10 | Journal article
Part of ISSN: 0161-5505
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 9)‎

New imaging techniques in the diagnosis of prostate cancer,Nieuwe beeldvormende technieken bij de diagnostiek van het prostaatcarcinoom

Tijdschrift voor Urologie
2019 | Journal article
EID:

2-s2.0-85074192434

Part of ISBN:

22114718 22113037

Contributors: Oprea-Lager, D.E.; Comans, E.F.I.
Source: Self-asserted source
Daniela-Elena Oprea-Lager via Scopus - Elsevier

Quantitative implications of the updated EARL 2019 PET–CT performance standards

EJNMMI Physics
2019-12 | Journal article
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Sensitivity of 18F-fluorodihydrotestosterone PET-CT to count statistics and reconstruction protocol in metastatic castration-resistant prostate cancer

EJNMMI Research
2019-12 | Journal article
Part of ISSN: 2191-219X
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer

European Journal of Nuclear Medicine and Molecular Imaging
2019-08 | Journal article
Part of ISSN: 1619-7070
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting

European Urology Oncology
2019-08 | Journal article
Part of ISSN: 2588-9311
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?

Urologic Oncology: Seminars and Original Investigations
2019-03 | Journal article
Contributors: Bernard H.E. Jansen; Jakko A. Nieuwenhuijzen; Daniela E. Oprea-Lager; Marit J. Yska; Anne P. Lont; Reindert J.A. van Moorselaar; André N. Vis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

[<sup>68</sup>Ga]PSMA-PET/CT imaging in prostate cancer diagnosis,[<sup>68</sup>Ga]PSMA-PET/CT-imaging bij de diagnostiek van prostaatkanker

Tijdschrift voor Urologie
2018 | Journal article
EID:

2-s2.0-85040225992

Part of ISBN:

22114718 22113037

Contributors: Vis, A.N.; Jansen, B.; Oprea-Lager, D.E.
Source: Self-asserted source
Daniela-Elena Oprea-Lager via Scopus - Elsevier

Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group

The Lancet Oncology
2018-10 | Journal article
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Prognostic Value of [ 18 F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics
2018-06 | Journal article
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group

European Journal of Cancer
2018-03 | Journal article
Contributors: Nandita M. deSouza; Yan Liu; Arturo Chiti; Daniela Oprea-Lager; Géraldine Gebhart; Bernard E. Van Beers; Ken Herrmann; Frederic E. Lecouvet
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT

Clinical Genitourinary Cancer
2017-10 | Journal article
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial

European Journal of Nuclear Medicine and Molecular Imaging
2017-08 | Journal article
Part of ISSN: 1619-7070
Part of ISSN: 1619-7089
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

PET-Guided Stereotactic Irradiation of Prostate Cancer Lymph Node Metastases

Journal of Nuclear Medicine
2017-01 | Journal article
Part of ISSN: 0161-5505
Part of ISSN: 2159-662X
Source: Self-asserted source
Daniela-Elena Oprea-Lager
grade
Preferred source (of 2)‎

Accuracy and precision of partial-volume correction in oncological PET/CT studies

Journal of Nuclear Medicine
2016 | Journal article
EID:

2-s2.0-84991406676

Part of ISBN:

2159662X 01615505

Contributors: Cysouw, M.C.F.; Kramer, G.M.; Hoekstra, O.S.; Frings, V.; De Langen, A.J.; Smit, E.F.; Van Den Eertwegh, A.J.M.; Oprea-Lager, D.E.; Boellaard, R.
Source: Self-asserted source
Daniela-Elena Oprea-Lager via Scopus - Elsevier
Items per page:
Page 1 of 2

Peer review (27 reviews for 6 publications/grants)

Review activity for EClinicalMedicine. (1)
Review activity for EJNMMI research. (3)
Review activity for European journal of nuclear medicine and molecular imaging. (20)
Review activity for European urology open science. (1)
Review activity for Molecular imaging and biology (1)
Review activity for The lancet oncology. (1)